BTV ta ba da rahoton martanin sinadarai game da cutar ta TIANGEN BIOTECH

Bayan barkewar cutar ta COVID-19, kwamitin gudanarwa na Park Science na Zhongguancun ya ba da jerin sabbin fasahohi, kayayyaki da ayyuka don karfafa tallafin fasahar kimiyya don yaki da cutar.TIANGEN BIOTECH (BEIJING) CO., LTD.yana cikin jerin tare da wasu.

Samfuran fasaha da sabis da ke cikin jerin sun ƙunshi abubuwa da yawa da suka shafi yaƙar cutar, kamar gano ƙwayoyin cuta, R&D na rigakafi, jiyya na asibiti, kariyar likita, ganewar hankali, da bincike da sakin bayanan cutar.

A watan Maris, rukunin rukunin BTV na "Beijing Ta Jirgin Kasa" ya yi hira da TIANGEN BIOTECH a wurin game da yakin da ake yi na kwayoyin cutar.An watsa labarin a cikin shirin "Beijing Ta Train" na tashar Kuɗi na BTV a ranar 12 ga Afrilu.

Kamar yadda wani upstream maroki na nucleic acid hakar da ganewa reagent albarkatun kasa a kasar Sin, TIANGEN BIOTECH (BEIJING) CO., LTD.ya ci gaba da tallafawa bincike da rigakafin kamuwa da cutar kwalara a kasar Sin, kuma ya ba da kayan masarufi don gano kwayar cutar fiye da mutane miliyan 10 a cikin gano cututtukan HFMD da H1N1.A cikin 2019, TIANGEN BIOTECH ya ba da kiwo na alade da raka'a keɓewa tare da masu cire acid nucleic ta atomatik da hakar acid nucleic da gano abubuwan ganowa na aladu sama da miliyan 30.